Flores, Haze Cadden D.

HRN: 23-35-41  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2023
AMPICILLIN 1GM (VIAL)
07/17/2023
07/23/2023
IVT
390mg
Now Then Q24
Neonatal Sepsis
Waiting Final Action 
07/17/2023
CEFOTAXIME 500MG (VIAL)
07/17/2023
07/23/2023
IVT
260mg
Now Then Q12
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: